FDA Extends Comment Period, Announces Public Workshop on Drug Repurposing

The FDA is extending the comment period by 30 days for the Request for Information on Drug Repurposing for Unmet Medical Needs.

On May 12, 2026, the FDA issued a Request for Information to solicit input and comments on FDA's efforts with respect to drug repurposing to address unmet medical needs.